Significance of Concurrent Chemoradiotherapy as Primary Treatment in Patients with Metastatic Cervical Cancer.
biomarker
concurrent chemoradiotherapy
metastatic cervical cancer
prognosis
tumor size
Journal
Current oncology (Toronto, Ont.)
ISSN: 1718-7729
Titre abrégé: Curr Oncol
Pays: Switzerland
ID NLM: 9502503
Informations de publication
Date de publication:
29 04 2021
29 04 2021
Historique:
received:
18
03
2021
revised:
20
04
2021
accepted:
26
04
2021
entrez:
5
5
2021
pubmed:
6
5
2021
medline:
25
9
2021
Statut:
epublish
Résumé
(1) This study investigated the prognostic impact of tumor size in patients with metastatic cervical cancer. (2) Methods: Seventy-three cervical cancer patients in our institute were stratified into two groups based on distant metastasis: para-aortic lymph node metastasis alone (IIIC2) or spread to distant visceral organs with or without para-aortic lymph node metastasis (IVB) to identify primary tumor size and concurrent chemoradiotherapy. (3) Results: The overall survival (OS) for patients with a tumor >6.9 cm in size was significantly poorer than that for patients with a tumor ≤6.9 cm in the IVB group (
Identifiants
pubmed: 33946737
pii: curroncol28030155
doi: 10.3390/curroncol28030155
pmc: PMC8161771
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1663-1672Références
J Gynecol Oncol. 2010 Sep;21(3):186-90
pubmed: 20922142
Am J Med. 1983 May;74(5):786-94
pubmed: 6837602
Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):492-9
pubmed: 15925454
Int J Gynaecol Obstet. 2018 Oct;143 Suppl 2:22-36
pubmed: 30306584
Gynecol Oncol. 2007 Nov;107(2):310-5
pubmed: 17826822
Gynecol Oncol. 2007 Jun;105(3):823-5
pubmed: 17363045
Lancet. 2019 Aug 10;394(10197):497-509
pubmed: 31255301
Oncol Rep. 2008 Feb;19(2):497-503
pubmed: 18202800
Gynecol Oncol. 2013 Jun;129(3):517-21
pubmed: 23528928
Lung Cancer. 2012 Dec;78(3):276-81
pubmed: 23043970
Cancer. 1991 Jun 1;67(11):2776-85
pubmed: 2025841
Arch Gynecol Obstet. 2012 Jun;285(6):1685-93
pubmed: 22173823
Gynecol Oncol. 2008 Jan;108(1):100-5
pubmed: 17920108
Int J Gynecol Cancer. 2016 Mar;26(3):528-33
pubmed: 26825839
Radiat Oncol. 2015 Apr 04;10:77
pubmed: 25884833
J Gynecol Oncol. 2019 Mar;30(2):e40
pubmed: 30740962
J Natl Compr Canc Netw. 2019 Jan;17(1):64-84
pubmed: 30659131
Gynecol Oncol. 2015 Apr;137(1):34-9
pubmed: 25662625
Eur J Cancer. 2013 Oct;49(15):3262-73
pubmed: 23751569
Int J Cancer. 2019 May 1;144(9):2144-2152
pubmed: 30474210
Cancer Res Treat. 2013 Sep;45(3):193-201
pubmed: 24155678
Eur J Surg Oncol. 2018 Jul;44(7):1062-1068
pubmed: 29753611
J Clin Oncol. 2015 Jul 1;33(19):2136-42
pubmed: 25732170